Philip Cooksey, Chief Financial Officer (CFO), and Dr. Tim Pflederer, Chief Medical Officer (CMO), have been appointed to Evergreen Nephrology’s leadership team.
As the new CFO at Evergreen, Philip Cooksey brings a plethora of expertise with him from his time as an investment banker at Goldman Sachs and Lazard, as well as leadership and management of Humana’s financial operations for the insurance and healthcare services businesses.
Evergreen Nephrology has announced the appointment of two executives: Dr. Tim Pflederer, CMO, and Philip Cooksey, CFO.
Philip Cooksey, the new CFO of Evergreen Nephrology, brings a wealth of expertise to the position. He led and oversaw Humana’s financial operations for both the insurance and healthcare services segments and had a previous career in investment banking at Goldman Sachs and Lazard.
Philip Cooksey, the new CFO of Evergreen Nephrology, brings a wealth of expertise to the position. He led and oversaw Humana’s financial operations for both the insurance and healthcare services segments and had a previous career in investment banking at Goldman Sachs and Lazard.
Dr. Tim Pflederer, MD, is welcomed to Evergreen Nephrology and will start as CMO on April 1. Dr. Pflederer has been treating patients with kidney illness for thirty years. He has also been president of the Renal Physician Association and other organizations that work to improve healthcare across the country. Currently, he serves as president of Renal Care Associates in Peoria, Illinois.
Dr. Tim Pflederer, MD, is welcomed to Evergreen Nephrology and will start as CMO on April 1. Dr. Pflederer has been treating patients with kidney illness for thirty years. He has also been president of the Renal Physician Association and other organizations that work to improve healthcare across the country. Currently, he serves as president of Renal Care Associates in Peoria, Illinois.
Cooksey stated, Evergreen offers a unique set of resources, such as its strong clinician partnerships, that combine to create a platform to improve quality and outcomes for some of the most vulnerable Americans. He was thrilled to be joining the company at this pivotal juncture in its growth trajectory, and He was looking forward to collaborating with exceptional colleagues throughout the entire organization to further our purpose of enhancing health, cutting expenses, and raising engagement with our beneficiaries.
Additionally, Dr. Tim Pflederer, MD, is welcomed to Evergreen. He will start serving as CMO on April 1. Dr. Pflederer has been treating patients with kidney illness for thirty years. He has also been president of the Renal Physician Association and other organizations that work to improve healthcare across the country. Currently, he serves as president of Renal Care Associates in Peoria, Illinois.
According to Dr. Pflederer, He has had the honor to work with Evergreen in a number of capacities over the last two years as we worked together to improve the quality of life for patients living with chronic kidney disease (CKD). The resources and support that Evergreen’s approach offers nephrologists like myself are unparalleled, adding value to the treatment we provide and giving patients and their families hope. He is ecstatic to be involved in this groundbreaking project.
Personalized plans and treatment are provided by Evergreen, a multifaceted organization, to suit the needs of individuals with chronic renal disease at each stage of their journey. The 37 million persons in the United States who suffer from renal disease can live far better lives thanks to these initiatives.
According to Adam Boehler, Executive Chairman of Evergreen Nephrology, the company works in collaboration with nephrology practices across the nation to increase transplants for patients with chronic kidney disease (CKD), slow down the progression of the disease, reduce needless hospitalizations, and move care closer to home. Because of these initiatives, it’s imperative that we have strong leaders who support our goals and the difference we are making; Philip Cooksey and Dr. Tim Pflederer are the ideal candidates to take on these responsibilities alongside our executive team.
Cooksey’s demonstrated ability to boost financial performance and put sound financial plans into place will be crucial in helping Evergreen reach its next stage of expansion and success. Furthermore, I have no doubt that Dr. Pflederer’s years of experience working directly with patients will provide him with a special viewpoint that is crucial in advancing our dedication to enhancing the lives of people we serve.
Kidney care at Evergreen Nephrology is patient-centered. Evergreen strives to provide people with chronic kidney disease with a comprehensive care experience by enabling them to participate actively in their own health through shared decision-making, in partnership with our nephrologist and payor partners. Evergreen is setting the national standard for renal care with tailored, physician-led treatment through its network of over 700 provider partners spread across 17 states. Find out more about our initiatives to promote individualized treatment plans and value-based care for people with renal disease.
